The first detects aberrantly methylated BMP3 and NDRG4, mutant KRAS, β-actin and haemoglobin in a single faecal sample and has a sensitivity of 92.3% and 69.2% for detecting CRC and advanced precancerous lesions, respectively [103]. This evidence concerns the gene KRAS and colorectal carcinoma.